Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes.

about

Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes.

Item

http://www.wikidata.org/entity/Q48329250

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@en

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@nl

type

Item

label

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@en

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@nl

prefLabel

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@en

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@nl

P1476

Insulin deficiency with and wi ...... eatectomy and type 1 diabetes.

@en

P2093

Fumimaru Niwano

http://www.w3.org/2001/XMLSchema#string

Ippei Matsumoto

http://www.w3.org/2001/XMLSchema#string

Sara Yasutake

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Takeyama

http://www.w3.org/2001/XMLSchema#string

Yumiko Kawabata

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice

Insulin and Glucagon: Partners for Life.

Identification of glucagon in the gastrointestinal tract.

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.

Making insulin-deficient type 1 diabetic rodents thrive without insulin.

Glucagon antagonism as a potential therapeutic target in type 2 diabetes.

Glucagon is the key factor in the development of diabetes.

The New Biology and Pharmacology of Glucagon.

P304

1084-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12799

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29288524

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

6123030

http://www.w3.org/2001/XMLSchema#string